Skip to Content
Loading...
  Loading...
Employer Quick Look

Xellia Pharmaceuticals USA, LLC

 
Overview

Xellia Pharmaceuticals is a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. Xellia is wholly owned by Novo Holdings A/S since 2013 and headquartered in Copenhagen, Denmark. We have five state-of-the-art manufacturing facilities located in; Denmark, Hungary, China and in the U.S. 

At a glance: 

  • Over 1,800 employees in countries worldwide
  • Over 115 years’ experience in the development, manufacture and supply of fermented and semi-synthetic APIs and FDFs
  • We supply our anti-infective products to more than 500 pharmaceutical companies in over 70 countries
  • We are a leading supplier of important anti-infectives Vancomycin and Colistimethate Sodium (CMS)
  • We first launched several of our own-label products to the US hospital market in 2018
  • Our R&D team is providing innovative solutions to develop value-added anti-infectives from core portfolio products


A Career With Xellia


Our people make us what we are. We aim to attract the most talented, passionate employees in our industry and to earn their loyalty and commitment. We support our employees through comprehensive people resource processes, ensuring that every employee is treated fairly and has a voice which is listened to and valued.


Xellia's purpose is to save and enhance lives by leading the fight against infections. Our goal is to lead the fight against infections by providing anti-infective solutions against multi-drug resistant micro-organisms. We build our culture on four values which together with our Leadership Promise serve as an enabler and reinforcement to our behaviors and actions as employees and leaders. We truly believe that we can only succeed in our purpose through the engagement and expertise of our employees. As a company we want to foster a culture which strengthens employee engagement and the expertise of its employees. 

Social Responsibility

In January 2018, Xellia Pharmaceuticals announced another three year partnership (2018-2020) with SOS Children’s Villages Denmark, to support the SOS Children’s Villages Family Strengthening Program in Eldoret, Kenya. 

The collaboration with SOS Children’s Villages Denmark, began in 2015, with the successful three year partnership (2015-2017) in support of the SOS Medical Center in Eldoret, Kenya.

In addition to Xellia’s corporate funding and the annual fundraising event, colleagues from various Xellia sites were actively fundraising during 2018 for three additional important causes to further support SOS Children’s Villages in Eldoret. These initiatives helped provide sanitary towels, the renovation of a local preschool and for the treatment for jiggers. Furthermore, our sites in Chicago, Il, USA; Zagreb, Croatia; Taizhou, China and Budapest, Hungary, have supported their local SOS Children’s Villages as well through either monetary donations or volunteer time.